Small-Scale Bioreactors Market Report 2026

Small-Scale Bioreactors Market Overview

• Small-Scale Bioreactors market size has reached to $2.48 billion in 2025 • Expected to grow to $5.09 billion in 2030 at a compound annual growth rate (CAGR) of 15.5% • Growth Driver: Surge In Biopharmaceutical R&D Investments Drives Small-Scale Bioreactors Market Growth • Market Trend: Innovative Solutions Enhanced Market Growth • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Small-Scale Bioreactors Market?

Small-scale bioreactors, also known as laboratory-scale or pilot-scale vessels, refer to the process development and optimization that are used for conducting biological experiments, cultivating microorganisms, cells, or tissues, and studying biological processes under controlled conditions. These bioreactors are designed to mimic and simulate the environment necessary for the growth and metabolism of biological cultures. The main types of products in small-scale bioreactors are reusable bioreactors and single-use bioreactors. Reusable bioreactors refer to bioprocessing systems that can be sterilized and reused for multiple batches of cell culture or fermentation. It generates capacities of 5 ML–100 ML, 100 ML–250 ML, 250 ML–500 ML, 500 ML–1 L, 1L–3 L, and 3L–5 L. It uses various molecules such as monoclonal antibodies, stem cells, recombinant proteins, vaccines, and gene therapy, and are used by various end-users such as pharmaceutical and biopharmaceutical companies, contract research organizations (CROs), contract manufacturing organizations (CMOs), and academic and research institutes.

What Is The Small-Scale Bioreactors Market Growth Forecast?

The small-scale bioreactors market size is expected to see rapid growth in the next few years. It will grow to $5.09 billion in 2030 at a compound annual growth rate (CAGR) of 15.5%. The growth in the forecast period can be attributed to expansion of cell therapy pipelines, increased biomanufacturing startups, demand for cost-effective systems, automation adoption, growth in emerging biotech hubs. Major trends in the forecast period include increased adoption of single-use bioreactors, rising demand from research labs, integration of automation systems, growth in modular bioprocessing, expansion of academic research funding.

Global Small-Scale Bioreactors Market Segmentation

1) By Product: Reusable Bioreactors, Single-Use Bioreactors 2) By Capacity: 5 ML-100 ML, 100 ML-250 ML, 250 ML -500 ML, 500 ML-1 L, 1L-3L, 3L-5L 3) By Molecules: Monoclonal Antibodies, Stem Cells, Recombinant Proteins, Vaccines, Gene Therapy 4) By End User: Pharmaceutical And Biopharmaceutical Companies, Contract Research Organizations (CROs) And Contract Manufacturing Organizations (CMOs), Academic And Research Institutes Subsegments: 1) By Reusable Bioreactors: Stirred Tank Bioreactors, Bubble Column Bioreactors, Airlift Bioreactors, Fixed-Bed Bioreactors 2) By Single-Use Bioreactors: Disposable Bioreactor Bags, Pre-sterilized Single-Use Systems, Flexible Single-Use Bioreactor Systems, Integrated Single-Use Platforms

What Is The Driver Of The Small-Scale Bioreactors Market?

The surge in biopharmaceutical research and development (R&D) investments is significantly contributing to the growth of the small-scale bioreactors market going forward. Small-scale bioreactors are essential tools for process development in biopharmaceutical manufacturing. Researchers use these reactors to study and optimize the parameters involved in cell culture, fermentation, and downstream processing before scaling up to larger production volumes. This ensures that the manufacturing process is efficient, cost-effective, and meets quality standards. For instance, in 2023, according to Office for National Statistics, a UK-based, government agency, the UK government’s net spending on research and development (R&D) increased to £17.4 ($22.1 billion) billion in 2023, up from £16.1 billion ($20.45 billion) in 2022, marking an 8.2% rise. As a result, the increased investments in research and development by biopharmaceutical companies are propelling the small-scale bioreactors industry.

Key Players In The Global Small-Scale Bioreactors Market

Major companies operating in the small-scale bioreactors market are Sartorius AG, Thermo Fisher Scientific Inc., Merck KGaA, Miltenyi Biotec B.V. & Co. KG, Solaris Biotechnology Srl, Infors AG, Getinge AB, 2mag AG, Adolf Kuhner AG, Biosan, Esco Micro Private Limited, Hanil Scientific Inc., HiTec Zang GmbH, H.E.L Group, Finesse Solutions Inc., Applikon Biotechnology BV, PBS Biotech Inc., Danaher Corporation, Eppendorf AG, General Electric Company, Sartorius Stedim Biotech, Cytiva, Kuhner Shaker

Global Small-Scale Bioreactors Market Trends and Insights

Major companies operating in the small-scale bioreactor market are focused on developing innovative products such as fixed-bed bioreactor to enhance efficiency in bioprocessing and improve scalability for microbial and cell culture applications. A fixed-bed bioreactor refers to a type of bioreactor in which microorganisms or enzymes are immobilized on a solid support within a stationary bed, allowing for continuous or batch processing of substrates as they flow through the reactor. For instance, in October 2024, Univercells Technologies, a Belgium-based biotechnology company, launched the Scale-XTM Nexo bioreactor. It is a miniaturized system aimed at enhancing cell culture process development. This innovative bioreactor is designed to streamline and accelerate development timelines for researchers, ultimately reducing costs by up to 60% compared to traditional methods.

What Are Latest Mergers And Acquisitions In The Small-Scale Bioreactors Market?

In June 2023, Culture Biosciences Inc., a US-based cell and microbial culture platform provider, formed a partnership with Cytiva Bioscience Holding Ltd, to innovate in upstream bioprocessing. The collaboration aims to advance the development and manufacturing of new therapies by integrating Culture Biosciences’ automated bioreactor technology with Cytiva’s bioprocessing expertise, enhancing efficiency, scalability, and innovation in the biopharmaceutical production process. Cytiva is a US-based life sciences company focused on providing technologies and services that enable the development and manufacture of biotherapeutics.

Regional Outlook

North America was the largest region in the small-scale bioreactors market in 2025.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Small-Scale Bioreactors Market?

The small-scale bioreactors market consists of the sales of shake flasks, microtiter plates, benchtop bioreactors, bioreactor vessels, gas supply systems, fixed bed bioreactors, fluidized bed bioreactors, photo-bioreactors, single-use bioreactors (SUBs), perfusion bioreactors, hollow fiber bioreactors, spinner flasks, rotary drum bioreactors, and plug-flow bioreactors. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Small-Scale Bioreactors Market Report 2026?

The small-scale bioreactors market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the small-scale bioreactors industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.